ARTICLE | Company News
Aduro BioTech, BioSante deal
April 25, 2011 7:00 AM UTC
Aduro received exclusive, worldwide rights to BioSante's GVAX cancer vaccines to treat pancreatic and prostate cancer for use in combination with its Listeria monocytogenes bacterial vectors. Aduro al...